Advertisement

Topics

Latest "Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women" News Stories

20:02 EST 18th January 2019 | BioPortfolio

Here are the most relevant search results for "Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women" found in our extensive news archives from over 250 global news sources.

More Information about Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women for you to read. Along with our medical data and news we also list Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women Clinical Trials, which are updated daily. BioPortfolio also has a large database of Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women Companies for you to search.

Showing "Effect South Beach Diet trade Using trade Products" News Articles 1–25 of 26,000+

Friday 18th January 2019

CHINA AID, the Key Gateway to the Chinese Elderly Care Market, to Take Place in Shanghai in 2019

SHANGHAI, Jan. 18, 2019 /PRNewswire/ -- CHINA AID 2019, hosted by Shanghai Intex Exhibition Co., Ltd., is taking place from Wednesday 11th to Friday 13th June 2019 at the Shanghai New International Expo Centre (SNIEC) in Pu Dong, Shanghai. By the end of 2017, the number of seniors in China over the age of 60 surpassed 241 million, accounting for 17.3 percent of the country's total population. The...


FDA chief: Agency has money for about 5 more weeks of drug approvals

Photo of Cigna Building Blessings in a Backpack in Orlando Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees in Orlando celebrating the combination of the two companies by filling 1,500 backpacks with food for children at the Metrowest and Westpointe Elementary Schools in Orlando. The event marked the beginning of a new global $25 million ...


Definitive Healthcare buys HIMSS Analytics’ data services biz

Through the transaction, Definitive Healthcare gains HIMSS Analytics’ Logic, Predict, Analyze and custom research products.

AdvaMed Code Update Focuses On Compliance Standards

AdvaMed has revised its industry Code of Ethics. The revised code, which will come into effect in 2020, includes new...   

Photo of Cigna Building Blessings in a Backpack in Phoenix Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees at the Cigna Norterra office celebrating the combination of the two companies by filling 1,500 backpacks with food for children at the Nevitt Elementary School in Tempe, Arizona. The event marked the beginning of a new global $25 mi...

Bioethicists Call for Oversight of Consumer ‘Neurotechnologies’ with Unproven Benefits

(Medical Xpress) – The marketing of direct-to-consumer “neurotechnologies” can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or “read” one’s emotional state. However, many of these increasingly popular products aren’t fully supported by science … Read More

Photo of Cigna Building Blessings in a Backpack in Franklin Lakes, N.J. Available on Business Wire's Website and the Associated Press Photo Network; Food Going to Bronx, N.Y. School

A photo is available on Business Wire's website and the Associated Press photo network of employees at the Express Scripts office in Franklin Lakes, N.J. celebrating the company’s combination with Cigna by filling backpacks with food for children at Public School 20 in the Bronx, New York. The event marked the beginning of a new global $25 million progra...

Planetary diet for longer life: Less meat, more vegetables

Meat is unhealthy both for the people who eat too much of it and for the planet, the report says.

SOHM, Inc. Announce Share Holder update and Outlook for 2019

Chino Hills, 01/18/2019 / 16:34, CET/CEST - EQS Newswire - Sohm, Inc. CHINO HILLS, CA / ACCESSWIRE / January 18, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical, Nutraceutical and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today some of developments with the company which it started during 2017 and 2018 r...

PhRMA Adds Genentech, Gilead To Its Ranks Ahead Of House Democrats’ Drug Pricing Scrutiny

Roche, through Genentech, returns to the PhRMA fold after leaving the trade group in 2009; Gilead is a first-time member;...   

Study links opioid epidemic to painkiller marketing

(Reuters Health) - Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses.

Two-Thirds of Poor U.S. Women Can’t Afford Menstrual Pads, Tampons: Study

(U.S. News & World Report) – A study of nearly 200 poor women living in the St. Louis area found that two out of three had to go without feminine hygiene products at least once over the prior year, due … Read More

Cardiol Therapeutics Inc. Closes Over-Allotment

Cardiol Therapeutics Inc. (TSX:CRDL)  ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer, announced today that the underwriters for the Company's initial public offering (the "Offering") have exercised their over-allotment option (the "Over-Allotment Option") to purchase an ad...

DTC Ads For Genetic Tests Increased 18-Fold Over 20 Years, Study Says

The number of direct-to-consumer advertisements for molecular-based tests rose exponentially from 1997 to 2016, according to a medical marketing analysis...   

Synmosa Biopharma Corp 4114 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySynmosa Biopharma Corp Synmosa is a pharmaceutical company that manufactures, markets and distributes generic medicines. The company produces nonpharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It offers products in the therapeutic areas of cardiovascular, respiratory, urology, sex hormone, gynecology and ca...

Metrasens Instigates a Patent Infringement Action in China against Nanjing Cloud Magnet Electronic Technology Limited

Metrasens, a global leader in MRI Safety solutions for healthcare facilities announces today that it has commenced a patent infringement action in the Chinese courts against Nanjing Cloud Magnet Electronic Technology Limited. MALVERN, England (PRWEB) January 18, 2019 Metrasens is a leading provider of advanced magnetic detection technologies. Founded in the UK, Metrasens has become a global indus...

#VisualAbstract: Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction The ARTEMIS Randomized Clinical Trial

1. In this randomized controlled trial, medication vouchers were associated with a small increase in patient-reported persistence with P2Y12 inhibitors for patients who had suffered a myocardial infarction (MI). 2. Medication vouchers were not associated with reduced major adverse cardiovascular events (MACE) in these patients. Evidence Rating Level: 1 (Excellent)       Study Rundown: Anti...

Lilly's cancer therapy Lartruvo fails study, shares drop

Eli Lilly and Co said its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial and it expects to take a charge in the first quarter of 2019, sending its shares down more than 2 percent in early trade.

Dark Days For Sun As Governance Saga Escalates

Allegations of corporate governance lapses continued to singe Sun, but there is little clarity on which way things are headed...    

Oral Hepatoselective Glucokinase Activator Promising in T2DM

FRIDAY, Jan. 18, 2019 -- Use of the oral hepatoselective glucokinase activator (GKA) TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes, according to a study published online Jan....

Opinion: Drones delivering medical supplies have caught on quickly in Africa and the South Pacific. It's time for the U.S. to invest in the technology. https://buff.ly/2W1OUgb 

Opinion: Drones delivering medical supplies have caught on quickly in Africa and the South Pacific. It's time for the U.S. to invest in the technology. https://buff.ly/2W1OUgb 

HVAC Manufactured Air Curtain Systems for Revolving Doors

Product AnnouncementBerner introduced the RevolvAirTM Air Curtain System for Revolving Doors—the first air curtain system for revolving doors engineered by a U.S. manufacturer.

Depression in Chronic Pain: Might Opioids Be Responsible?

Might depression be an unrecognized, potentially reversible adverse effect of opioid therapy in patients receiving opioids for chronic pain? Pain

Contaminated Umbilical Cord Blood-Derived Stem Cell Products

This investigation highlights the serious potential risks to patients of stem cell therapies administered for unapproved and unproven uses other than hematopoietic or immunologic reconstitution. Morbidity & Mortality Weekly Report


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks